Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open Label, Randomized, Multicenter, Controlled Clinical Study of INFUSE® Bone Graft Used as an Alternative to Autogenous Bone Graft for Vertical Alveolar Ridge Augmentation

NCT01308996 is registered in ClinicalTrials.gov with Medtronic Spinal and Biologics as lead sponsor.

NCT NCT01308996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01308996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open Label, Randomized, Multicenter, Controlled Clinical Study of INFUSE® Bone Graft Used as an Alternative to Autogenous Bone Graft for Vertical Alveolar Ridge Augmentation
Lead sponsor
Medtronic Spinal and Biologics
Phase
Not applicable
Overall status
Withdrawn
Start date
April 30, 2012
Completion date
September 30, 2017
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar bone loss in mandible, edentulous alveolar ridge in mandible